Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, January 03, 2024
Ampersand Biomedicines has acquired AbCheck s.r.o., a technology company specializing in antibody discovery for challenging targets and formerly a wholly-owned subsidiary of Affimed GmbH. Ampersand, a multi-product platform company focused on ...
read more
Wednesday, January 03, 2024
Frontage Laboratories, Inc. has successfully completed the acquisition of the Bioanalytical and Drug Metabolism & Pharmacokinetics businesses of Accelera S.r.l (Accelera) through its wholly-owned subsidiary Frontage Europe S.r.l. Accelera, a Contract...
read more
Wednesday, December 27, 2023
Jemincare, a leading pharmaceutical company from China, announced that its wholly owned subsidiary company, Shanghai Jemincare Pharmaceutical Co., Ltd., recently received 6 approvals of clinical trials for its innovative drugs in the field of cancer,...
read more
Wednesday, December 27, 2023
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:
read more
Wednesday, December 27, 2023
Nectin Therapeutics Ltd. (Nectin), a biotechnology firm dedicated to developing innovative targeted immunotherapies to overcome resistance to approved immune oncology treatments, has announced significant advancements in its Phase 1 clinical trial of...
read more
Wednesday, December 20, 2023
Polyplus, a key player in advanced biologics and cell and gene therapy production within the Sartorius Group, has entered into a collaborative venture with MarkHerz, a Korean cell and gene therapy (CGT) contract development and manufacturing ...
read more
Wednesday, December 20, 2023
The European Medicines Agency (EMA) and the U.S. FDA have jointly unveiled the "EMA–FDA joint Q&As on Quality and GMP aspects of PRIME/Breakthrough therapy applications."
Body:
The European Medicines Agency (EMA) and the U.S. Food and Drug ...
read more
Wednesday, December 20, 2023
Veeva Systems has revealed that Recipharm, a prominent global contract development and manufacturing organization (CDMO), will optimize its quality operations using Veeva Vault QMS, Veeva Vault QualityDocs, and Veeva Vault Training.
read more
Wednesday, December 20, 2023
Thermo Fisher Scientific Inc. has introduced CorEvidence, a proprietary cloud-based data lake platform aimed at optimizing pharmacovigilance case processing and safety data management procedures. This innovative platform complements Thermo Fisher's ...
read more
Wednesday, December 20, 2023
Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) specializing in biopharmaceuticals, has announced a major client collaboration for its upcoming Rentschler Biopharma Manufacturing Center (RBMC) ...
read more
Wednesday, December 20, 2023
Multiply Labs, a cutting-edge robotics company specializing in automated manufacturing systems for personalized drugs, has entered into a non-exclusive partnership with Akron Bio, a leading supplier of essential materials and services for advanced ...
read more
Tuesday, December 19, 2023
Piramal Pharma Solutions (PPS), a key player in Contract Development and Manufacturing Organization (CDMO) services under Piramal Pharma Ltd., has inaugurated its advanced antibody-drug conjugate (ADC) manufacturing facility in Grangemouth, Scotland,...
read more
Tuesday, December 19, 2023
Elligo Health Research® has recently undergone a leadership transition, with the company's founder and former CEO, John Potthoff, Ph.D., taking on the role of Chairman. Stepping into the position of CEO is Barry Simms, formerly the Chief Operating ...
read more
Monday, December 18, 2023
Charles River Laboratories International, Inc. announced an important milestone in their strategic collaboration to manufacture CASGEVY™ (exagamglogene autotemcel [exa-cel]). CASGEVY is approved in some countries for certain eligible patients.
read more
Monday, December 18, 2023
Checkpoint Therapeutics, Inc. disclosed that the FDA issued a Complete Response Letter (CRL) in connection with the cosibelimab biologic license application (BLA) intended for the treatment of individuals with metastatic or locally advanced cutaneous...
read more